Managing the transition to the new regulation: this is a seminar you cannot afford to miss as you put in place your strategies for the new environment.
4-5 Mar 2020
& 19-20 Oct 2020
GBP 1,499 1,299 *
EUR 2,099 1,819 *
USD 2,338 2,026 *
* When you book before 17 Jan
During a period of great uncertainty and opportunity within the medical technology and diagnostics sectors, this seminar will help you prepare for these changes and operate successfully in Europe. The programme will provide in-depth coverage of the new regulations and how they will be implemented by member states and Notified Bodies. You will hear the latest thoughts on clinical development, safety monitoring, the role of authorised representatives, economic operators, and
the implications of Brexit.
There will be plenty of opportunities to discuss the implications of the changes with our expert faculty, and you will gain valuable guidance on successful implementation of the regulatory changes for your company products.
This is a seminar you cannot afford to miss as you put in place your strategies for the new environment.
The seminar will provide key guidance and interpretation of the changes to the regulations and will be of value to all those who are involved with placing a medical device on the market, and anyone who requires an essential overview of the new MDR and its impact on the industry and working practices.
Chair’s welcome and introduction
Dr David Jefferys
Introduction and background to the new regulation
Successful implementation of the MDR
Notified Bodies: how the changes will impact NBs and manufacturers – including the new rules for IVD conformity assessment
Increased vigilance and post-market surveillance − how to comply
IVDs and companion diagnostics
Clinical investigations − what is required?
Other essential considerations
Other essential considerations (continued)
Discussion session and key take-home messages
Janette Benaddi is a business mentor, international speaker/trainer and consultant to the medical device industry. Janette has over 25 years’ experience of managing pre and post market clinical studies in both devices and pharmaceuticals. Janette has worked with several multinational organizations in various clinical, regulatory and marketing roles. She has extensive experience of conducting clinical studies with medical device products as well as regulatory expertise for CE marking of devices. Specifically she has been involved in writing and reviewing hundreds of Clinical evaluation reports for the medical device industry, she has also provided training to Notified bodies in this subject.
Janette qualified as a registered nurse in 1984, she has a BSc in Management studies, a Diploma in Company Direction, and a Diploma in Management studies, holds a teaching certificate and is a Chartered Scientist and Chartered Director. Janette sits on several committees in the device community and industry and has been an instrumental advocate of improving and advancing medical device research in the UK. Janette has published several articles relating to medical device regulation and clinical studies.
Dr David Jefferys is currently Senior Vice President with Eisai responsible for Global Regulatory, Government Relations, Public Affairs and Patient Safety (EMEA, Russia and Australasia). After qualifying in medicine he worked in clinical and academic medicine, before spending 20 years as a senior regulator for both medicines and medical devices. He was executive director of the UK Medicines Control Agency, CEO and Director of the MDA, joint CEO of MHRA. He was involved in the establishment of the European Medicines Agency, CPMP/CHMP member and MRFG and PER scheme chairman. For the last ten years he has worked in industry and chairs several key committees for ABPI, Efpia and IFPMA. He has lectured and published extensively in drug and device regulation and on benefit risk evaluation.
Theresa Jeary works for SFL as Head of Combination Products. She was previously Head of the Notified Body for Medical Devices at LRQA, where she was responsible for Devices Drug products and Class III Medical Conformity Assessment for a wide range of medical devices, including In-Vitro Fertilization Media and Solutions for Organ Preservation. Theresa has over 25 years’ experience working in both the Pharmaceutical and Medical Device industries and has worked in a variety of roles across the full development cycle from product concept and early stage development, process transfer, validation and regulatory departments, and has been a part of the team for many commercially available medicinal and medical device products.
Theresa first introduction to the Medical device Industry was as the R&D Manager for a medical device manufacturer, with responsibility for the development of several device drug combination products, with the core technology utilizing bovine collagen. Having been impressed by the innovative nature and speed of development in the Medical Device Industry, she then pursued a move to the other side of the “fence” and into the Notified Body world of Conformity Assessment. First, at BSI as a Certification Manager in the General Device group, and now with Lloyds Register Quality Assurance (LRQA).
Over the years, she has conducted many successful consultations with a large number of the European Competent Authorities as well as the European Medicines Agency (EMA) as well as reviewing the classification of borderline products. She holds a Master’s Degree in Pharmaceutical Science and is eligible to be a Pharmaceutical Qualified Person.
Peter Rose is the Managing Director for Maetrics in Europe. Having worked in the medical device industry for over 25 years, he has a wealth of experience and knowledge in quality systems and regulatory affairs. He is a lead auditor and a qualified microbiologist, and has a particular expertise in sterilization.
Maetrics provides consultancy, training, auditing services, business process outsourcing and project management of quality management systems and worldwide regulatory affairs including clinical evaluation reports for the medical device, pharmaceutical, in-vitro diagnostic and life science industries.
In addition to his Maetrics responsibilities, Peter is also a Director of Medilink East Midlands and sits on the MHRA Medical Device Industry Liaison Group, the ABHI Technical Policy Committee, the ABHI MDR Implementation Working Group and the ABHI Brexit Working Group. He has also been a guest lecturer at three universities (The University of Nottingham, Nottingham Trent University and The University of Sheffield), and is a Trustee of The Rock Church, West Bridgford.
|4-5 Mar 2020|
|4-5 Mar 2020||Rembrandt Hotel, London||GBP 1,499.00
+ VAT @ 20.00%
Until 17 Jan*
|19-20 Oct 2020|
|19-20 Oct 2020||Rembrandt Hotel, London||GBP 1,499.00
+ VAT @ 20.00%
|Online registration unavailable: this date is nearing full capacity; please call us on 020 7749 4730 to register.|
* Note the early booking discount cannot be combined with any other offers or promotional code